Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders

• Published in: BMC psychiatry Vol. 23; no. 1; pp. 1 - 797
• Main Authors: Chamoun, Karam, Mouawad, Joseph, Salameh, Pascale, Sacre, Hala, Haddad, Ramzi, Khabbaz, Lydia Rabbaa, Megarbane, Bruno, Hajj, Aline
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 01.11.2023; BioMed Central; BMC
• Subjects: Analysis; Arabic; Development and progression; Drug abuse; Drug addiction; Drug overdose; Drug use; Emergency medical care; Fatalities; Heroin; Insomnia; Lebanon; Medical research; Medical screening; Medicine, Experimental; Mental disorders; Mood; Mood disorders; Narcotics; Opioid risk Tool; Opioid use disorder; Opioids; Pandemics; Population studies; Prescription drugs; Principal components analysis; Psychiatry; Public health; Questionnaires; Scale validation; Sedatives; Sleep; Sleep disorders; Sociodemographics; Socioeconomic factors; Substance abuse; Substance use disorder; Lebanon; United States > US; Beirut Lebanon
• ISSN: 1471-244X; 1471-244X
• DOI: 10.1186/s12888-023-05304-8

Abstract Background The revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and validate the Arabic version of ORT-OUD in the Lebanese population and assess its clinical validity in a sample of patients with OUD. Methods This cross-sectional study in the Lebanese population used several validated scales to assess the risk of OUD, including the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Other tools evaluated chronotype and sleep and mood disturbances. Principal component analysis with Varimax rotation was applied to assess ORT-OUD construct validity. Convergent validity with the Arabic version of ASSIST was evaluated. The ORT-OUD criterion validity was then assessed in a clinical sample of patients with OUD. Results This study included 581 participants. The prevalence of the OUD risk in the Lebanese population using the ORT-OUD scale and the ASSIST-opioids scale was estimated at 14.5% and 6.54%, respectively. No items of the ORT-OUD were removed; all items converged over a solution of four factors with an eigenvalue > 1, explaining a total of 68.2% of the variance (Cronbach’s alpha = 0.648). The correlation coefficients between the ORT-OUD total score and ASSIST subscales were as follows: ASSIST-opioids (r = 0.174; p = < 0.001), ASSIST-sedatives (r = 0.249; p < 0.001), and ASSIST-alcohol (r = 0.161; p = < 0.001). ORT-OUD clinical validation showed a correlation with ASSIST-opioids (r = 0.251; p = 0.093) and ASSIST-sedatives (r = 0.598; p < 0.001). Higher ORT-OUD scores were associated with a family and personal history of alcohol and substance consumption and higher insomnia and anxiety scores. Conclusions This study is the first to validate the Arabic version of ORT-OUD in the Lebanese population, an essential step towards improving the detection and management of OUD in this population.